Recombinant human antithrombin drug decreases risk to pregnancy and surgery patients with hereditary antithrombin deficiency

and patients with a serious blood disorder that causes excessive clotting have responded well to treatment with a man-made anti-clotting .


Read more

Related posts

Leave a Reply